Early Diagnosis Improves Clinical Outcomes in PsA Early Diagnosis Improves Clinical Outcomes in PsA
Psoriatic arthritis diagnosis by a rheumatologist within a year of symptom onset improved long-term clinical outcomes, a study showed.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - March 18, 2024 Category: Rheumatology Tags: Rheumatology Source Type: news

No Rise in Cancer Risk With Non-TNF Inhibitor bDMARDs in RA No Rise in Cancer Risk With Non-TNF Inhibitor bDMARDs in RA
Non-TNF inhibitor biologic disease-modifying antirheumatic drugs did not appear to increase the risk for cancer in patients with RA in a real-world cohort study.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - March 18, 2024 Category: Rheumatology Tags: Rheumatology Source Type: news

Rheum Workforce May Have Grown, But It's Still Not Enough Rheum Workforce May Have Grown, But It's Still Not Enough
The US rheumatology workforce grew by more than 20% from 2009 to 2019, according to new research, but even if this growth continued, it would not be enough to meet the increasing demand.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 18, 2024 Category: Consumer Health News Tags: Rheumatology Source Type: news

Hyperuricemia Subtypes in Gout Show Distinct Traits Hyperuricemia Subtypes in Gout Show Distinct Traits
The distinct biologic features of different hyperuricemia subtypes call for the development of tailored, subtype-dependent, genetics-based therapies for gout or hyperuricemia.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 18, 2024 Category: Consumer Health News Tags: Rheumatology Source Type: news

AI in Rheumatology: Current and Future Roles AI in Rheumatology: Current and Future Roles
AI brings opportunities to improve workflow, make writing and certain tasks easier, and facilitate drug development, experts said at the Rheumatology Winter Clinical Symposium.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 15, 2024 Category: Consumer Health News Tags: Rheumatology Source Type: news

Rheumatology Workforce Increased 20 Percent From 2009 to 2019
THURSDAY, March 14, 2024 -- The overall number of clinically active rheumatology providers grew more than 20 percent during the last decade, according to a study published online Feb. 25 in Arthritis& Rheumatology.Melissa L. Mannion,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 14, 2024 Category: Pharmaceuticals Source Type: news

Valley Fever Screens Found Lagging for Rheum Patients in Endemic Areas
(MedPage Today) -- Medicare data indicated that most patients with rheumatologic conditions and living in areas where valley fever (aka coccidioidomycosis) is endemic were not screened for the disease before starting disease-modifying anti-rheumatic... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - March 14, 2024 Category: Rheumatology Source Type: news

Rheumatologist Found Dead; How COVID Changed Lives; Olivia Munn's Breast Cancer
(MedPage Today) -- Note that some links may require registration or subscription. A Connecticut rheumatologist was found dead after his arrest in a child sex abuse investigation. (WTNH) Multiple class action lawsuits may join forces accusing... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 14, 2024 Category: Hematology Source Type: news

Why Is MoonLake Immunotherapeutics Stock Trading Higher Today?
On Sunday, MoonLake Immunotherapeutics MLTX announced that continued treatment with Nanobody sonelokimab led to significant improvements across all key outcomes at 24-week data from the ARGO trial in psoriatic arthritis (PsA). The 207-patient ARGO trial demonstrated that the primary endpoint, theā€¦#pasi #abbvieincs #abbvhumira #acr50pasi100 #acr #mda #tnf #moonlake (Source: Reuters: Health)
Source: Reuters: Health - March 11, 2024 Category: Consumer Health News Source Type: news

Leflunomide: An Overlooked Drug for Your Treatment Toolkit? Leflunomide: An Overlooked Drug for Your Treatment Toolkit?
Overlooked in the biologic era, it still has a place.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 11, 2024 Category: Consumer Health News Tags: Rheumatology Source Type: news

RA Outcomes Worsened by Depression and Anxiety RA Outcomes Worsened by Depression and Anxiety
Patients with anxiety or depression were less likely to achieve low disease activity and improve their symptoms compared with those without these mental health conditions.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 11, 2024 Category: Consumer Health News Tags: Rheumatology Source Type: news

Safe GC Tapering in Lupus: Reducing Flares, Damage Safe GC Tapering in Lupus: Reducing Flares, Damage
Cautious tapering of glucocorticoids might be feasible even in serologically active clinically quiescent patients with systemic lupus erythematosus.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 11, 2024 Category: Consumer Health News Tags: Rheumatology Source Type: news

August 2, 2017: Meeting of the Arthritis Advisory Committee Meeting Announcement - 08/01/2017
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 8, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

UPDATED PUBLIC PARTICIPATION INFORMATION: August 3, 2017: Meeting of the Arthritis Advisory Committee Meeting Announcement - 08/02/2017
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 8, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Approves Second Tocilizumab Biosimilar FDA Approves Second Tocilizumab Biosimilar
Tocilizumab-aazg (Tyenne) is approved in both intravenous and subcutaneous formulations.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - March 7, 2024 Category: Internal Medicine Tags: Rheumatology Source Type: news